OptiNose, Inc. (NASDAQ:OPTN) Q3 2024 Earnings Conference Call November 12, 2024 8:00 AM ET
Company Participants
Jonathan Neely - Vice President of Investor Relations and Business Development
Ramy Mahmoud - Chief Executive Officer
Terry Kohler - Chief Financial Officer
Paul Spence - Chief Commercial Officer
Conference Call Participants
Thomas Flaten - Lake Street Capital Markets
David Amsellem - Piper Sandler
Glen Santangelo - Jefferies
Matthew Caufield - H.C. Wainwright
Operator
Good day, and welcome to the OptiNose Third Quarter 2024 Earnings Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions] As a reminder, this call may be recorded.
I would now like to turn the call over to Jonathan Neely, Vice President, Investor Relations. Please go ahead.
Jonathan Neely
Good morning, and thank you for joining us today as we review OptiNose's third quarter 2024 performance and our plans for the year ahead. I am joined today by our CEO, Dr. Ramy Mahmoud; our new CFO, Terry Kohler; and our Chief Commercial Officer, Paul Spence. The slides that will be presented on this call can be viewed on our website, optinose.com, in the Investors section.
Before we start, I would like to remind you that our discussions during this conference call will include forward-looking statements. All statements that are not historical facts are hereby identified as forward-looking statements. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those indicated by such statements.
Additional information regarding these factors and forward-looking statements is discussed under the cautionary note on forward-looking statements section of the earnings release that we issued today as well as under the Risk Factors section and elsewhere in OptiNose's most recent Form 10-K and 10-Q that are filed with the SEC and available at their website, sec.gov, and on our website at optinose.com.
You're cautioned not to place undue reliance on forward-looking statements. The forward-looking statements during this conference call speak only as of the original date of this call or any earlier date indicated in such statement, and we undertake no obligation to update or revise any of these statements. We will now make prepared remarks, and then we will move to a question-and-answer session.
With that, I will now turn the call over to Ramy.
Ramy Mahmoud
Thank you, Jonathan, and thank you to everyone listening for joining us this morning. We appreciate you joining us for our third quarter 2024 update. Before we get into the call, I want to offer a warm welcome to Terry Kohler, our new Chief Financial Officer. Terry brings significant expertise in leading financial strategy for commercial stage branded pharmaceutical products and is a strong new addition to our leadership team. Welcome, Terry.